Cite
HARVARD Citation
Deb, A. et al. (2022). Cost-effectiveness of the 15-valent pneumococcal conjugate vaccine for high-risk adults in Switzerland. Expert review of vaccines. pp. 711-722. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Deb, A. et al. (2022). Cost-effectiveness of the 15-valent pneumococcal conjugate vaccine for high-risk adults in Switzerland. Expert review of vaccines. pp. 711-722. [Online].